Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
GLIMEPIRIDA MABO 4 mg COMPRIMIDOS EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- GLIMEPIRIDA — 4 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- No packs currently marketed
Packs
GLIMEPIRIDA MABO 4 mg COMPRIMIDOS EFG, 30 comprimidos
30 pcs
National code
Not marketed654728Strength of this pack 4 mg
GLIMEPIRIDA MABO 4 mg COMPRIMIDOS EFG, 120 comprimidos
120 pcs
National code
Not marketed655866Strength of this pack 4 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 67519Official data
- Marketing authorisation holder
- MABO FARMA S.A.Official data
- Authorised
- Jan 27, 2006Official data
- Authority form code
- 40Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.